Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 5 | $1,282,056 |
Sells | 30 | $1,304,748 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Aug 2023 20:35 | PRTK | Paratek Pharmaceuticals Inc | BIGHAM MICHAEL | Exec. Chairman of the Board | 09 Aug 2023 | Sale | 31,250 | 2.2 | 68,750 | D |
10 Aug 2023 20:38 | PRTK | Paratek Pharmaceuticals Inc | BRENNER RANDALL B. | Chief Development & Regulatory | 09 Aug 2023 | Sale | 27,603 | 2.2 | 60,727 | D |
10 Aug 2023 20:32 | PRTK | Paratek Pharmaceuticals Inc | HASKEL WILLIAM M. | CLO, General Counsel & Sec. | 09 Aug 2023 | Sale | 34,526 | 2.2 | 75,957 | D |
10 Aug 2023 20:26 | PRTK | Paratek Pharmaceuticals Inc | LOH EVAN | CEO | 09 Aug 2023 | Sale | 48,967 | 2.2 | 107,727 | D |
29 Mar 2023 16:31 | PRTK | Paratek Pharmaceuticals Inc | DONDERO JAMES D | 10% | 23 Mar 2023 | Purchase | 100,000 | 1.73 | 173,000 | I |
29 Mar 2023 16:31 | PRTK | Paratek Pharmaceuticals Inc | DONDERO JAMES D | 10% | 22 Mar 2023 | Purchase | 106,000 | 1.77 | 187,620 | I |
29 Mar 2023 16:31 | PRTK | Paratek Pharmaceuticals Inc | DONDERO JAMES D | 10% | 21 Mar 2023 | Purchase | 242,500 | 1.74 | 421,950 | I |
29 Mar 2023 16:31 | PRTK | Paratek Pharmaceuticals Inc | DONDERO JAMES D | 10% | 20 Mar 2023 | Purchase | 105,137 | 1.4 | 147,192 | I |
29 Mar 2023 16:31 | PRTK | Paratek Pharmaceuticals Inc | DONDERO JAMES D | 10% | 17 Mar 2023 | Purchase | 234,863 | 1.5 | 352,294 | I |
23 Feb 2023 14:27 | PRTK | Paratek Pharmaceuticals Inc | STEIN JEFFREY | Director | 21 Feb 2023 | Sale | 7,000 | 1.9 | 13,300 | D |
23 Feb 2023 14:22 | PRTK | Paratek Pharmaceuticals Inc | FRANSON TIMOTHY R | Director | 21 Feb 2023 | Sale | 7,000 | 1.88 | 13,160 | D |
22 Dec 2022 16:51 | PRTK | Paratek Pharmaceuticals Inc | WOODROW ADAM | President & Chief Commercial | 21 Dec 2022 | Sale | 6,750 | 1.99 | 13,432 | D |
22 Dec 2022 16:44 | PRTK | Paratek Pharmaceuticals Inc | LOH EVAN | CEO | 21 Dec 2022 | Sale | 23,489 | 1.99 | 46,743 | D |
22 Dec 2022 16:38 | PRTK | Paratek Pharmaceuticals Inc | HASKEL WILLIAM M. | CLO, General Counsel & Sec. | 21 Dec 2022 | Sale | 7,007 | 1.99 | 13,944 | D |
22 Dec 2022 16:33 | PRTK | Paratek Pharmaceuticals Inc | BRENNER RANDALL B. | Chief Development & Regulatory | 21 Dec 2022 | Sale | 4,539 | 1.99 | 9,033 | D |
22 Dec 2022 16:26 | PRTK | Paratek Pharmaceuticals Inc | BIGHAM MICHAEL | Exec. Chairman of the Board | 21 Dec 2022 | Sale | 15,750 | 1.99 | 31,342 | D |
14 Dec 2022 20:11 | PRTK | Paratek Pharmaceuticals Inc | WOODROW ADAM | President & Chief Commercial | 13 Dec 2022 | Sale | 6,253 | 1.96 | 12,256 | D |
14 Dec 2022 20:05 | PRTK | Paratek Pharmaceuticals Inc | HASKEL WILLIAM M. | CLO, General Counsel & Sec. | 13 Dec 2022 | Sale | 23,584 | 1.96 | 46,225 | D |
14 Dec 2022 20:08 | PRTK | Paratek Pharmaceuticals Inc | LOH EVAN | CEO | 13 Dec 2022 | Sale | 61,919 | 1.96 | 121,361 | D |
14 Dec 2022 20:00 | PRTK | Paratek Pharmaceuticals Inc | BIGHAM MICHAEL | Exec. Chairman of the Board | 13 Dec 2022 | Sale | 31,891 | 1.96 | 62,506 | D |
14 Dec 2022 20:03 | PRTK | Paratek Pharmaceuticals Inc | BRENNER RANDALL B. | Chief Development & Regulatory | 13 Dec 2022 | Sale | 18,177 | 1.96 | 35,627 | D |
14 Dec 2022 20:11 | PRTK | Paratek Pharmaceuticals Inc | WOODROW ADAM | President & Chief Commercial | 12 Dec 2022 | Sale | 3,820 | 1.98 | 7,564 | D |
14 Dec 2022 20:05 | PRTK | Paratek Pharmaceuticals Inc | HASKEL WILLIAM M. | CLO, General Counsel & Sec. | 12 Dec 2022 | Sale | 14,410 | 1.98 | 28,532 | D |
14 Dec 2022 20:08 | PRTK | Paratek Pharmaceuticals Inc | LOH EVAN | CEO | 12 Dec 2022 | Sale | 37,831 | 1.98 | 74,905 | D |
14 Dec 2022 20:00 | PRTK | Paratek Pharmaceuticals Inc | BIGHAM MICHAEL | Exec. Chairman of the Board | 12 Dec 2022 | Sale | 19,484 | 1.98 | 38,578 | D |
14 Dec 2022 20:03 | PRTK | Paratek Pharmaceuticals Inc | BRENNER RANDALL B. | Chief Development & Regulatory | 12 Dec 2022 | Sale | 11,105 | 1.98 | 21,988 | D |
01 Nov 2022 20:00 | PRTK | Paratek Pharmaceuticals Inc | WOODROW ADAM | President & Chief Commercial | 28 Oct 2022 | Sale | 4,563 | 3.47 | 15,834 | D |
01 Nov 2022 19:55 | PRTK | Paratek Pharmaceuticals Inc | HASKEL WILLIAM M. | CLO, General Counsel & Sec. | 28 Oct 2022 | Sale | 4,382 | 3.47 | 15,206 | D |
01 Nov 2022 19:58 | PRTK | Paratek Pharmaceuticals Inc | LOH EVAN | CEO | 28 Oct 2022 | Sale | 8,805 | 3.47 | 30,553 | D |
01 Nov 2022 19:51 | PRTK | Paratek Pharmaceuticals Inc | BIGHAM MICHAEL | Exec. Chairman of the Board | 28 Oct 2022 | Sale | 6,000 | 3.47 | 20,820 | D |
01 Nov 2022 19:53 | PRTK | Paratek Pharmaceuticals Inc | BRENNER RANDALL B. | Chief Development & Regulatory | 28 Oct 2022 | Sale | 3,516 | 3.47 | 12,201 | D |
10 Aug 2022 21:06 | PRTK | Paratek Pharmaceuticals Inc | LOH EVAN | CEO | 09 Aug 2022 | Sale | 44,519 | 2.66 | 118,421 | D |
10 Aug 2022 21:00 | PRTK | Paratek Pharmaceuticals Inc | BIGHAM MICHAEL | Exec. Chairman of the Board | 09 Aug 2022 | Sale | 28,637 | 2.66 | 76,174 | D |
10 Aug 2022 21:02 | PRTK | Paratek Pharmaceuticals Inc | BRENNER RANDALL B. | Chief Development & Regulatory | 09 Aug 2022 | Sale | 19,608 | 2.66 | 52,157 | D |
10 Aug 2022 21:04 | PRTK | Paratek Pharmaceuticals Inc | HASKEL WILLIAM M. | CLO, General Counsel & Sec. | 09 Aug 2022 | Sale | 22,453 | 2.66 | 59,725 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)